MCL1 and cancer: Hence, many cancer cells are likely ‘primed’ to undergo apoptosis upon the administration of BAD and NOXA mimetics that displace BIM/PUMA from BCL-2/BCL-XL and MCL-1, respectively, to activate BAX/BAK12, 13, 14.